entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 22:39:17 - browse：357

Adderall XR capsules are displayed on Feb. 24, 2023. Drug shortages are growing in the United States, and experts see no clear path to resolving them. — There has been a persistent shortage of the ADHD drug Adderall. Jenny Kane/AP

My first exposure to pharmaceutical shortages happened in 2017 as a new-to-practice nurse working on an inpatient oncology unit. A hurricane in Puerto Rico had left the U.S. short of sodium chloride minibags. Health care providers nationwide were tasked to modify standard medication preparation and administration practices, such as changing medications from IV to oral delivery, avoiding prepping IV lines with saline, or providing IV drugs by push rather than infusion. I was working in a heavily resourced academic institution. It felt absurd that I couldn’t even appropriately administer medications, but I figured this was an emergency.

Eventually, the shortage ended. But it was not an isolated incident.

The recent spotlight on shortages of essential medicines, such as cancer therapies and ADHD drugs, has brought attention to a longstanding public health crisis. Prescription drug shortages across drug classes have been on the radar of our governing bodies for decades. Nearly 10 years ago, up to 83% of oncologists surveyed could not prescribe a preferred chemotherapy agent due to shortages. Yet, the problem persists, with new shortages being identified at alarming rates. Recent reports indicate drug shortages grew by 30% in the past year. At the end of 2022, there were national shortages of 295 medications, including essentials like anesthetics, chemotherapies, and antibiotics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： House panel takes first step toward fixing drug shortages

WSS

Chamber of Commerce, DOJ clash in court over drug prices

PBMs drew scrutiny in House hearing — and so did pharma

Food makers to regulators: Ultra

Long Covid needs a new name — and a new frame

Regeneron agrees to White House price limits on anti

PBMs drew scrutiny in House hearing — and so did pharma

hotspot

entertainment

focus

What does generative AI mean for health care? We asked experts

Akili changes sales model for its ADHD video game treatment

Apple is now the first public company to be valued at $3 trillion

The unintended consequences of overturning Roe v. Wade

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

After affirmative action ruling, medical educators look to 'holistic review'

Hospitals consider fixing cancer drug shortages on their own

Anesthesiologist group: stop taking Ozempic before surgery

How the messy conversation about Dolly changed bioethics

Wikipedia

How housing is health care on Long Island

Will the IRA bring competition to the biologics market?

Popular nasal decongestant doesn't actually relieve congestion

How medical schools plan to diversify without affirmative action

Midwives could help bridge maternal health disparities in the U.S.

IRA could hurt research into orphan drugs for rare diseases

knowledge

hotspot

focus

entertainment